menu
    • menu
    [{"orgOrder":0,"company":"Huadong Pharmaceutical","sponsor":"Provention Bio","pharmaFlowCategory":"D","therapeuticArea":"Immunology","country":"U.S.A","productType":"Large molecule","year":"2021","type":"Collaboration","leadProduct":"PRV-3279","moa":"CD32B","graph1":"Immunology","graph2":"Phase I","graph3":"Huadong Pharmaceutical","amount2":0.28999999999999998,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Immunology","amount2New":0.28999999999999998,"dosageForm":"Intravenous Infusion","sponsorNew":"Huadong Pharmaceutical \/ Huadong","highestDevelopmentStatusID":"6","companyTruncated":"Huadong Pharmaceutical \/ Huadong"}]

    Find Clinical Drug Pipeline Developments & Deals by Huadong Pharmaceutical

    Menu

    Huadong Pharmaceutical

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Huadong Pharmaceutical

                            China arrow
                            Pharma, Lab & Chemical Expo
                            Not Confirmed

                            Huadong Pharmaceutical

                            China arrow
                            Pharma, Lab & Chemical Expo
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : PRV-3279

                            Therapeutic Area : Immunology

                            Study Phase : Phase I

                            Recipient : Provention Bio

                            Deal Size : $293.0 million

                            Deal Type : Collaboration

                            DEALS_DEV arrow-down

                            Provention Bio and Huadong Announce Strategic Collaboration to Develop and Commercialize PRV-3279 in Greater C...

                            Details : Provention Bio plans to begin a Phase 2a trial of PRV-3279 in systemic lupus erythematosus (SLE) in the second half of 2021 and expects a portion of such trial to be conducted in China.

                            Brand Name : PRV-3279

                            Molecule Type : Large molecule

                            Upfront Cash : $6.0 million

                            February 17, 2021

                            Lead Product(s) : PRV-3279

                            Therapeutic Area : Immunology

                            Highest Development Status : Phase I

                            Recipient : Provention Bio

                            Deal Size : $293.0 million

                            Deal Type : Collaboration

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth